Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) FCF Margin (2016 - 2025)

Bioadaptives' FCF Margin history spans 7 years, with the latest figure at 1494.47% for Q4 2025.

  • On a quarterly basis, FCF Margin changed N/A to 1494.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 2823.2%, a 85369.0% decrease, with the full-year FY2025 number at 2921.68%, down 95217.0% from a year prior.
  • FCF Margin hit 1494.47% in Q4 2025 for Bioadaptives, up from 3266.6% in the prior quarter.
  • Over the last five years, FCF Margin for BDPT hit a ceiling of 343.35% in Q1 2024 and a floor of 7623.11% in Q2 2024.
  • Historically, FCF Margin has averaged 1741.09% across 5 years, with a median of 1267.82% in 2023.
  • Biggest five-year swings in FCF Margin: crashed -519186bps in 2024 and later surged 417539bps in 2025.
  • Tracing BDPT's FCF Margin over 5 years: stood at 919.32% in 2021, then rose by 25bps to 690.36% in 2022, then tumbled by -84bps to 1267.82% in 2023, then plummeted by -501bps to 7623.11% in 2024, then skyrocketed by 80bps to 1494.47% in 2025.
  • Business Quant data shows FCF Margin for BDPT at 1494.47% in Q4 2025, 3266.6% in Q3 2025, and 3447.72% in Q2 2025.